NVCT
Price
$6.06
Change
+$0.14 (+2.36%)
Updated
Nov 14, 01:30 PM (EDT)
Capitalization
151.64M
116 days until earnings call
Intraday BUY SELL Signals
TVGN
Price
$0.44
Change
-$0.03 (-6.38%)
Updated
Nov 13 closing price
Capitalization
87.81M
Intraday BUY SELL Signals
Interact to see
Advertisement

NVCT vs TVGN

Header iconNVCT vs TVGN Comparison
Open Charts NVCT vs TVGNBanner chart's image
Nuvectis Pharma
Price$6.06
Change+$0.14 (+2.36%)
Volume$100
Capitalization151.64M
Tevogen Bio Holdings
Price$0.44
Change-$0.03 (-6.38%)
Volume$265.82K
Capitalization87.81M
NVCT vs TVGN Comparison Chart in %
NVCT
Daily Signal:
Gain/Loss:
TVGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NVCT vs. TVGN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCT is a StrongBuy and TVGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (NVCT: $5.92 vs. TVGN: $0.44)
Brand notoriety: NVCT and TVGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVCT: 65% vs. TVGN: 48%
Market capitalization -- NVCT: $151.64M vs. TVGN: $87.81M
NVCT [@Biotechnology] is valued at $151.64M. TVGN’s [@Biotechnology] market capitalization is $87.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCT’s FA Score shows that 0 FA rating(s) are green whileTVGN’s FA Score has 1 green FA rating(s).

  • NVCT’s FA Score: 0 green, 5 red.
  • TVGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both NVCT and TVGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCT’s TA Score shows that 3 TA indicator(s) are bullish while TVGN’s TA Score has 4 bullish TA indicator(s).

  • NVCT’s TA Score: 3 bullish, 6 bearish.
  • TVGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TVGN is a better buy in the short-term than NVCT.

Price Growth

NVCT (@Biotechnology) experienced а +4.41% price change this week, while TVGN (@Biotechnology) price change was -5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Reported Earning Dates

NVCT is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCT($152M) has a higher market cap than TVGN($87.8M). NVCT YTD gains are higher at: 9.427 vs. TVGN (-54.786). TVGN has higher annual earnings (EBITDA): 9.23M vs. NVCT (-22.97M). NVCT has more cash in the bank: 26.8M vs. TVGN (685K). NVCT (0) and TVGN (0) have equivalent revenues.
NVCTTVGNNVCT / TVGN
Capitalization152M87.8M173%
EBITDA-22.97M9.23M-249%
Gain YTD9.427-54.786-17%
P/E RatioN/A2.88-
Revenue00-
Total Cash26.8M685K3,912%
Total DebtN/A7.56M-
TECHNICAL ANALYSIS
Technical Analysis
NVCTTVGN
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
44%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 3 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
43%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 22 days ago
65%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
NVCT
Daily Signal:
Gain/Loss:
TVGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCPNF14.001.29
+10.15%
Olympus Corp.
AMYZF0.14N/A
+0.30%
RECYCLICO BATTERY MATERIALS INC.
MRPLY11.94N/A
N/A
Mr. Price Group Ltd.
FPLPF1.49N/A
N/A
VANQUIS BKG GROUP PLC
FRTN0.05N/A
-5.15%
Fortran Corp.

NVCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCT has been loosely correlated with ADMA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCT jumps, then ADMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-1.50%
ADMA - NVCT
36%
Loosely correlated
-4.62%
PDSB - NVCT
36%
Loosely correlated
-12.33%
SGMT - NVCT
29%
Poorly correlated
-12.24%
DSGN - NVCT
29%
Poorly correlated
-7.23%
TVGN - NVCT
28%
Poorly correlated
-4.60%
More

TVGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVGN has been loosely correlated with IVA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TVGN jumps, then IVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVGN
1D Price
Change %
TVGN100%
-0.91%
IVA - TVGN
37%
Loosely correlated
+4.65%
QCLS - TVGN
36%
Loosely correlated
+7.62%
MNOV - TVGN
27%
Poorly correlated
-2.48%
ABCL - TVGN
26%
Poorly correlated
-1.00%
COGT - TVGN
26%
Poorly correlated
+5.51%
More